Menu

Eagle Pharmaceuticals, Inc. EGRX

Full chart Compare
Set alert

Price alert · EGRX

All alert types
0.25 USD 0.00 (+0.00%)

At closeFeb 5, 2026, 4:00 PM EST

1.50 Day range 1.50
0.001 52-week range 3.94
YTD
-64.29%
1 year
-89.36%

Revenue & Expenses

Revenue → Gross Profit: $221.67MGross Profit → Net Income: $35.64MGross Profit → Selling, General & Admin: $106.63MGross Profit → Research & Development: $34.09MRevenue → Cost of Revenue: $94.94MGross Profit → Interest Expense: $4.04MGross Profit → Other Expenses: $15.48MGross Profit → Income Tax: $25.79MGross Profit$221.67MCost of Revenue$94.94MNet Income$35.64MSelling, General & Admin$106.63MResearch & Development$34.09MInterest Expense$4.04MOther Expenses$15.48MIncome Tax$25.79MRevenue$316.61M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

EGRX annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
316.61M171.55M187.80M195.89M213.31M
316.61M171.55M187.80M195.89M213.31M
94.94M42.18M45.47M60.90M61.92M
221.67M129.37M142.34M135.00M151.40M
140.71M126.60M109.38M113.18M115.54M
34.09M51.27M30.79M36.81M44.42M
106.63M75.32M78.60M76.37M60.51M
80.96M2.77M32.95M21.82M35.85M
4.04M1.64M2.58M2.69M2.74M
25.79M4.08M10.69M7.68M2.13M
35.64M-8.63M11.99M14.31M31.90M
35.64M-8.63M11.99M14.31M31.90M
35.64M-8.63M11.99M14.31M31.90M
35.64M-8.63M11.99M14.31M31.90M
2.76-0.660.891.042.16
2.76-0.660.891.042.16
2.73-0.660.871.012.09
65.48M-2.91M25.25M24.68M36.77M
65.48M-2.91M25.25M24.68M36.77M
12.93M13.05M13.48M13.75M14.77M
13.07M13.05M13.77M14.14M15.28M